Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease.
Autorzy:
Busnadiego I; Institute of Medical Virology, University of Zurich, Zurich, Switzerland. Abela IA; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland. FreyPM; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Hofmaenner DA; Institute of Intensive Care Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland. Scheier TC; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland. Schuepbach RA; Institute of Intensive Care Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland. Buehler PK; Institute of Intensive Care Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland. Brugger SD; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland. Hale BG; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
Pokaż więcej
Źródło:
PLoS biology [PLoS Biol] 2022 Jul 05; Vol. 20 (7), pp. e3001709. Date of Electronic Publication: 2022 Jul 05 (Print Publication: 2022).
Typ publikacji:
Clinical Study; Journal Article; Research Support, Non-U.S. Gov't
The importance of intravenous immunoglobulin treatment in critically ill patients with necrotizing soft tissue infection: a retrospective cohort study.
Autorzy:
Hofmaenner DA; Institute of Intensive Care Medicine, University Hospital Zurich, University of Zurich, Raemistrasse 100, 8091, Zurich, Switzerland. . Wendel Garcia PD; Institute of Intensive Care Medicine, University Hospital Zurich, University of Zurich, Raemistrasse 100, 8091, Zurich, Switzerland. Blum MR; Department of General Internal Medicine, Bern University Hospital (Inselspital), University of Bern, Bern, Switzerland.; Institute for Primary Health Care (BIHAM), University of Bern, Bern, Switzerland. David S; Institute of Intensive Care Medicine, University Hospital Zurich, University of Zurich, Raemistrasse 100, 8091, Zurich, Switzerland. Schuepbach RA; Institute of Intensive Care Medicine, University Hospital Zurich, University of Zurich, Raemistrasse 100, 8091, Zurich, Switzerland. Buehler PK; Institute of Intensive Care Medicine, University Hospital Zurich, University of Zurich, Raemistrasse 100, 8091, Zurich, Switzerland. FreyPM; Department of General Internal Medicine, Bern University Hospital (Inselspital), University of Bern, Bern, Switzerland.; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland. Zinkernagel AS; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland. Brugger SD; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2022 Feb 21; Vol. 22 (1), pp. 168. Date of Electronic Publication: 2022 Feb 21.
Bacterial colonization of handheld devices in a tertiary care setting: a hygiene intervention study.
Autorzy:
FreyPM; 1Department of General Internal Medicine, University Hospital Bern (Inselspital), University of Bern, 3010 Bern, Switzerland.; 2Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland. Marti GR; 1Department of General Internal Medicine, University Hospital Bern (Inselspital), University of Bern, 3010 Bern, Switzerland. Droz S; 3Institute for Infectious Diseases, University of Bern, Bern, Switzerland. de Roche von Arx M; Department of Internal Medicine, Hospital of Thun, Thun, Switzerland. Suter-Riniker F; 3Institute for Infectious Diseases, University of Bern, Bern, Switzerland. Aujesky D; 1Department of General Internal Medicine, University Hospital Bern (Inselspital), University of Bern, 3010 Bern, Switzerland. Brugger SD; 1Department of General Internal Medicine, University Hospital Bern (Inselspital), University of Bern, 3010 Bern, Switzerland.; 2Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
